Published in Ann Hum Genet on April 01, 1995
How partial C7 deficiency with chronic and recurrent bacterial infections can mimic total C7 deficiency: temporary restoration of host C7 levels following plasma transfusion. Immunology (1996) 0.91
Complement component C7 deficiency in a Spanish family. Clin Exp Immunol (2003) 0.90
C7 deficiency in an Irish family: a deletion defect which is predominant in the Irish. Clin Exp Immunol (1998) 0.87
Complement component C7 deficiency in two Spanish families. Immunology (2004) 0.81
Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation. Immunochemistry (1976) 2.89
Gliadin and reticulin antibodies in childhood coeliac disease. Lancet (1983) 2.11
New immunofluorescent blood test for gluten sensitivity. Arch Dis Child (1981) 1.88
Immunoglobulin heavy chain genes in humans are located on chromosome. Ann Hum Genet (1981) 1.85
Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut (1987) 1.79
IgA anti-gliadin antibodies in coeliac disease. Clin Exp Immunol (1981) 1.78
Structural relationship and complement fixing activity of sheep and other ruminant immunoglobulin G subclasses. Nature (1969) 1.57
Binding of wheat gliadin in vitro to reticulum in normal and dermatitis herpetiformis skin. J Invest Dermatol (1981) 1.57
Complement genetics in relation to HLA. Br Med Bull (1978) 1.55
Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining. Antimicrob Agents Chemother (2001) 1.50
Misdiagnosis of hereditary angio-oedema type 1 and type 2. Br J Dermatol (2003) 1.50
Autoimmunity in diarrhoeal disease. J Pediatr Gastroenterol Nutr (1985) 1.47
Anti-reticulin antibodies: useful adjunct to histopathology in diagnosing celiac disease, especially in a developing country. J Pediatr Gastroenterol Nutr (1989) 1.47
Heterogeneity in the complement-dependent bacteriolysis within the species of Borrelia burgdorferi. Med Microbiol Immunol (1997) 1.44
Arthritis and coeliac disease. Ann Rheum Dis (1985) 1.43
Combined genetic deficiency of C6 and C7 in man. Clin Exp Immunol (1978) 1.38
Anti-gliadin antibodies and small intestinal mucosal damage in dermatitis herpetiformis. Br J Dermatol (1981) 1.35
Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro. J Infect Dis (1998) 1.31
Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes. Immunology (2001) 1.31
The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect Immun (2002) 1.28
Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies. Br J Haematol (2001) 1.27
Allotypes of complement components in man. Transplant Rev (1976) 1.27
Inherited structural variation and linkage relationships of C7. J Immunogenet (1978) 1.26
Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants. J Hosp Infect (2000) 1.21
Restoration of specific immunological virginity. Nature (1974) 1.16
Studies on reticulin. I: Serological and immunohistological investigations of the occurrence of collagen type III, fibronectin and the non-collagenous glycoprotein of Pras and Glynn in reticulin. Br J Exp Pathol (1982) 1.13
Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur J Immunol (1995) 1.12
Glomerular deposition of mannose-binding lectin in human glomerulonephritis. Nephrol Dial Transplant (1999) 1.12
IgA in dermatitis-herpetiformis skin is dimeric. Lancet (1982) 1.11
Comparison of two laboratory methods for the determination of serum resistance in Borrelia burgdorferi isolates. Immunobiology (2000) 1.09
In vitro studies on the activity of amphotericin B and lipid-based amphotericin B formulations against Aspergillus conidia and hyphae. Mycoses (2002) 1.08
The immunopathogenesis of meningococcal disease. J Clin Pathol (2003) 1.07
Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release. Lancet (1992) 1.06
Anti-reticulin antibody in gluten sensitive enteropathy. Q J Med (1993) 1.06
Anti-tissue transglutaminase, anti-endomysium and anti-R1-reticulin autoantibodies-the antibody trinity of coeliac disease. Clin Exp Immunol (1999) 1.04
Autoantibodies against C1q: view on clinical relevance and pathogenic role. Clin Exp Immunol (1999) 1.03
Properties of a low molecular weight complement component C6 found in human subjects with subtotal C6 deficiency. Immunology (1992) 1.03
Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant. J Med Microbiol (2000) 1.02
C6: synthesis by the liver in vivo. J Exp Med (1977) 1.02
Linear IgA disease in adults. Br J Dermatol (1982) 1.01
Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation. J Immunol (1995) 1.00
IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy. J Clin Pathol (1999) 0.98
Autoantibodies against gut epithelium in child with small-intestinal enteropathy. Lancet (1982) 0.98
Coeliac disease and unfavourable outcome of pregnancy. Gut (2000) 0.97
Molecular basis of subtotal complement C6 deficiency. A carboxy-terminally truncated but functionally active C6. J Clin Invest (1995) 0.96
HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Dermatol (1999) 0.96
Immunoglobulins and immunoglobulin subclasses in the elderly. Ann Clin Biochem (2003) 0.96
Molecular bases of combined subtotal deficiencies of C6 and C7: their effects in combination with other C6 and C7 deficiencies. J Immunol (1996) 0.96
Genetic polymorphism of human plasminogen. Ann Hum Genet (1979) 0.95
Identifying immunoglobulin-A--deficient children and adults does not necessarily help the serologic diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr (1999) 0.94
Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro. Immunopharmacology (1999) 0.93
Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes. J Virol (2001) 0.93
Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein. Mol Immunol (2007) 0.93
Reference typing report for complement components C6, C7 and C9 including mutations leading to deficiencies. Exp Clin Immunogenet (1998) 0.92
The genetics of the sixth and seventh components of complement in the dog: polymorphism, linkage, locus duplication, and silent alleles. Biochem Genet (1983) 0.92
Antigliadin and antireticulin antibodies in screening for coeliac disease. Lancet (1987) 0.92
Complement-mediated adipocyte lysis by nephritic factor sera. J Exp Med (1993) 0.92
How partial C7 deficiency with chronic and recurrent bacterial infections can mimic total C7 deficiency: temporary restoration of host C7 levels following plasma transfusion. Immunology (1996) 0.91
Molecular bases of C7 deficiency: three different defects. J Immunol (1997) 0.90
Studies on the significance of the R1 anti-reticulin antibody associated with gluten sensitivity. Int Arch Allergy Appl Immunol (1985) 0.90
Linkage studies with C6. J Immunogenet (1977) 0.90
Iron-deficiency anaemia in premenopausal women. Lancet (1999) 0.90
A novel protein polymorphism of human complement C7 detected by a monoclonal antibody. Immunogenetics (1992) 0.90
Rapid activation of the complement system by cuprophane depends on complement component C4. Kidney Int (1998) 0.89
SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients. J Investig Allergol Clin Immunol (1998) 0.88
Tissue transglutaminase antibodies in dermatitis herpetiformis. Gastroenterology (1999) 0.88
The supportive role of complement in HIV pathogenesis. Immunol Rev (2001) 0.88
Evidence that the IgA in patients with linear IgA disease is qualitatively different from that of patients with dermatitis herpetiformis. Br J Dermatol (1984) 0.88
Correlation of a Glu/Ala substitution at position 98 with the complement C6 A/B phenotypes. Hum Mol Genet (1993) 0.88
Hereditary deficiency of the seventh component of complement and recurrent meningococcal infection: investigations of an Irish family using a novel haemolytic screening assay for complement activity and C7 M/N allotyping. Epidemiol Infect (1994) 0.87
Human beta 2-glycoprotein I: molecular analysis of DNA and amino acid polymorphism. Hum Genet (1993) 0.87
HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro. FEMS Immunol Med Microbiol (2001) 0.87
C7 deficiency in an Irish family: a deletion defect which is predominant in the Irish. Clin Exp Immunol (1998) 0.87
Organ-specific contribution to circulating C7 levels by the bone marrow and liver in humans. Eur J Immunol (1996) 0.87
Paradoxical reconstitution of complement activity following plasma transfusion of an individual with deficiency of the seventh component of complement. Immunology (1994) 0.86
HLA Cw*06 is not essential for streptococcal-induced psoriasis. Br J Dermatol (2006) 0.86
Evaluation of a high-throughput second antibody radiobinding assay for measuring IgA antibodies to human tissue transglutaminase. J Immunol Methods (1999) 0.85
Molecular basis of the complement C7 M/N polymorphism. A neutral amino acid substitution outside the epitope of the allospecific monoclonal antibody WU 4-15. J Immunol (1995) 0.85
Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157: indications for an animal reservoir. Epidemiol Infect (2005) 0.85
Anaemia in blood donors is not being properly investigated. BMJ (1999) 0.85
Type 1 diabetes mellitus masking primary antibody deficiency. J Clin Pathol (2000) 0.84
Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors. Immunobiology (1999) 0.84
Complement C7 deficiency: seven further molecular defects and their associated marker haplotypes. Hum Genet (1998) 0.84
Coeliac disease, anaemia and pregnancy. Clin Lab (2001) 0.83
The human complement C9 gene: identification of two mutations causing deficiency and revision of the gene structure. J Immunol (1997) 0.83
The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity. Diabetes Care (2001) 0.83
Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9. Immunology (2001) 0.83
Does the reticulin binding property of cereal proteins demonstrable in vitro have pathogenetic significance for coeliac disease? Gut (1985) 0.83
Serological evidence for human granulocytic ehrlichiosis in Western Austria. Eur J Clin Microbiol Infect Dis (2003) 0.83
Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit? Clin Exp Immunol (2003) 0.83
Complement component C6 and C7 haplotypes associated with deficiencies of C6. Ann Hum Genet (1995) 0.83
Immunoglobulin A deficiency on serological coeliac screening: an opportunity for early diagnosis of hypogammaglobulinaemia. Ann Clin Biochem (2012) 0.83
Ataxia, peripheral neuropathy, and anti-gliadin antibody. Guilt by association? J Neurol Neurosurg Psychiatry (2005) 0.82
Antibodies to extractable nuclear antigens. Has technological drift affected clinical interpretation? J Clin Pathol (2001) 0.82
c-ANCA as a marker of Wegener's disease. Lancet (1996) 0.82
Coeliac disease as cause of protracted diarrhoea in Indian children. Lancet (1988) 0.82
CR1 stump peptide and terminal complement complexes are found in the glomeruli of lupus nephritis patients. Clin Exp Immunol (1996) 0.82